We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Poolbeg Pharma Plc | LSE:POLB | London | Ordinary Share | GB00BKPG7Z60 | ORD 0.02P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 12.80 | 12.60 | 13.00 | 12.80 | 12.60 | 12.60 | 875,875 | 11:13:30 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 0 | -4.69M | -0.0094 | -13.62 | 64M |
Date | Subject | Author | Discuss |
---|---|---|---|
18/10/2023 12:47 | Well there ya have it.Almost back to where we started. | chica1 | |
18/10/2023 09:38 | Poolbeg Pharma has partnered with a Nasdaq-listed biopharma company on its oral delivery platformhttps://m.in | burtond1 | |
18/10/2023 07:11 | Singers maintain their BUY recommendation and PT of 21p. | adorling | |
17/10/2023 15:48 | I wouldn't imagine the rise today is sustainable. Even jovial Jeremy seemed underwhelmed this morning Would love to be wrong, | chica1 | |
17/10/2023 13:23 | Certainly not the show stopper that I thought it was when I saw the RNS! But the market has responded well regardless. If it can rise on an agreement like this, imagine what it can do on a polb001 licensing agreement! | discojames | |
17/10/2023 13:21 | Maybe the amount of support in cash terms to get it to the clinic. Share price reaction and lack of volume says it all. | chica1 | |
17/10/2023 13:04 | I don't know. The name of the partner is missing but other than that I don't know what they could have reasonably added. It's a collaboration or joint research agreement, not a licensing agreement. So Poolbeg get a bit of funding to work on using their delivery mechanism for a particular drug & target delivery site specified by the partner. If it doesn't work, then there will be some learnings which might help them do better next time. If it does work then it will act as proof of concept for the partner who might then be interested in a full licence agreement for the technology. Whether it merited a full RNS at this stage, I'm not so sure, but it keeps them moving forward and gives them another shot at a licensing agreement should they not manage to find anyone to partner POLB001 in the relatively near term. | 1gw | |
17/10/2023 12:49 | Sounds like a press release penned by Our Mr.Friel. The lack of detail is exasperating. | chica1 | |
17/10/2023 11:15 | Today's news is probably the reason that someone last week bought 1 million shares at 8p. In a half decent market, surely they would be a lot higher than they are now.Must be great value at 7.5p. | klosters65 | |
17/10/2023 09:26 | Maybe have a watch if these videos to expand on #POLB news Please see Vox & Proactive interviews following the release of today's RNS:https://twitter. | burtond1 | |
17/10/2023 08:50 | Does not bother me. | arlington chetwynd talbott | |
17/10/2023 08:47 | I think the lack of chatter says it all! | chica1 | |
17/10/2023 07:58 | Their partner is presumably being a bit coy at this stage of the game. Nothing wrong with that. This is good news. | arlington chetwynd talbott | |
17/10/2023 07:51 | A Nasdaq listed company with what market cap?There are companies trading on the Nasdaq with similar market caps to Poolbeg. If they're not going to tell us the Company they could at least give us a top range of how much the funding worth. Not dishing it but hey its very vague! | chica1 | |
17/10/2023 07:50 | Very nice. | arlington chetwynd talbott | |
17/10/2023 07:12 | Great news for #POLB this...They have signed a strategic collaboration agreement with a #Nasdaq listed #biopharma to develop an optimised #oraldrug for a metabolic condition using #POLB's licensed technologyThey are also optimistic that this can lead to a full licensing agreementhttps://www | burtond1 | |
14/10/2023 14:49 | Register for the webinar mentioned in the previous post here: | timbo003 | |
14/10/2023 10:57 | ShareSoc Webinar with Poolbeg Pharma(LON:POLB)25/1 | sharesoc | |
13/10/2023 13:51 | Getting NT for anything more than 10k | mrs robinson | |
09/10/2023 08:05 | A reminder for Jeremy Skillington's presentation at today's Drug Discovery World webinar:https://twit | burtond1 | |
05/10/2023 15:07 | I just bought some more at £0.0759 they are showing as a sell. I think this share is company is going well, some positive news coming out. | joseph moran | |
05/10/2023 11:17 | Thanks - a good read. Article by Amgen authors - they're obviously doing a lot of work in the AI area, and crying out for good data. | supernumerary | |
05/10/2023 09:53 | Decent article. Good this for #POLB Insightful article on how #AI can help to speed up #drugdiscovery.The high quality & unique nature of human challenge trial data can power AI-enabled drugdiscovery to identify novel & unlock meaningful insights into human diseasehttps://www.n | burtond1 | |
04/10/2023 20:27 | ? Poolbeg Pharma #POLB is revolutionizing the biopharma landscape! Leveraging #AI, they're accelerating drug discovery and setting new standards in infectious disease treatment. Game-changer ?? #DrugDiscovery #InnovationInHealth #InvestingWisdom tinyurl.com/3vem9b9c | elrico | |
04/10/2023 17:21 | Hotting up. Someone paid 8p for just over 1 million shares at 11:20 this morning. | klosters65 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions